Reports about acquired resistance to colistin in different bacteria species are increasing, including E. coli of animal origin, but reports of resistance in wild S. enterica of different serotypes from swine are not found in the literature. Results obtained with one hundred and twenty-six E. coli strains from diseased swine and one hundred and twenty-four S. enterica strains from diseased and carrier swine showed a frequency of 6.3% and 21% of colistin-resistant strains, respectively. When comparing the disk diffusion test with the agar dilution test to evaluate the strains, it was confirmed that the disk diffusion test is not recommended to evaluate colistin resistance as described previously. The colistin MIC 90 and MIC 50 values obtained...
Introduction: Carbapenems and colistin are the last-line antibiotics for treating Gram-negative bact...
Background: Antimicrobial resistance is a serious public-health problem throughout the world. Escher...
Colistin is frequently used as a growth factor or treatment against infectious bacterial diseases in...
Reports about acquired resistance to colistin in different bacteria species are increasing, includin...
Copyright © 2012 Adriano Savoia Morales et al. This is an open access article distributed under the ...
The One Health approach is not only focused on diseases and zoonosis control but also on antimi...
Colistin, a cationic polypeptide antibiotic, has reappeared in human medicine as a last-line treatme...
Colistin has been administrated for a long time in both human and veterinary medicine. Since the det...
Salmonellosis is one of the most important zoonoses in Europe and the world. Human infection may evo...
Transmission of colistin-resistant Enterobacterales from companion animals to humans poses a clinica...
Objective The widespread use of antibiotics in humans and animals has contributed to growing rate...
OBJECTIVE Polymyxins, especially colistin, have been used for years in veterinary medicine and were...
Colistin has been re-assessed as a critically important antimicrobial in humans due to its efficacy ...
The treatment of infections due to colistin-resistant (Col-E) and carbapenemase-producing (CPE) Ente...
BACKGROUND: Colistin is one of the last resort therapeutic options for treating carbapenemase-produc...
Introduction: Carbapenems and colistin are the last-line antibiotics for treating Gram-negative bact...
Background: Antimicrobial resistance is a serious public-health problem throughout the world. Escher...
Colistin is frequently used as a growth factor or treatment against infectious bacterial diseases in...
Reports about acquired resistance to colistin in different bacteria species are increasing, includin...
Copyright © 2012 Adriano Savoia Morales et al. This is an open access article distributed under the ...
The One Health approach is not only focused on diseases and zoonosis control but also on antimi...
Colistin, a cationic polypeptide antibiotic, has reappeared in human medicine as a last-line treatme...
Colistin has been administrated for a long time in both human and veterinary medicine. Since the det...
Salmonellosis is one of the most important zoonoses in Europe and the world. Human infection may evo...
Transmission of colistin-resistant Enterobacterales from companion animals to humans poses a clinica...
Objective The widespread use of antibiotics in humans and animals has contributed to growing rate...
OBJECTIVE Polymyxins, especially colistin, have been used for years in veterinary medicine and were...
Colistin has been re-assessed as a critically important antimicrobial in humans due to its efficacy ...
The treatment of infections due to colistin-resistant (Col-E) and carbapenemase-producing (CPE) Ente...
BACKGROUND: Colistin is one of the last resort therapeutic options for treating carbapenemase-produc...
Introduction: Carbapenems and colistin are the last-line antibiotics for treating Gram-negative bact...
Background: Antimicrobial resistance is a serious public-health problem throughout the world. Escher...
Colistin is frequently used as a growth factor or treatment against infectious bacterial diseases in...